Early Intrahepatic Cholestasis of Pregnancy & Adverse Outcomes
Early Intrahepatic Cholestasis of Pregnancy Linked to Increased Adverse Neonatal Outcomes
Table of Contents
New research highlights the significant risks associated with early diagnosis of intrahepatic cholestasis of pregnancy (ICP), suggesting that prolonged exposure to elevated bile acids might potentially be a key driver of adverse outcomes.
Understanding Intrahepatic Cholestasis of Pregnancy (ICP)
intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that affects pregnant women, typically in the third trimester. It is characterized by elevated levels of bile acids in the blood, which can lead to a range of complications for both mother and baby. While ICP is often diagnosed later in pregnancy, a recent study has shed light on the particular challenges and increased risks associated with an earlier diagnosis.
Key Findings on Adverse Outcomes
A comprehensive analysis of 1247 singleton,live gestations complicated by ICP revealed a notable difference in outcomes based on the timing of diagnosis. Of the participants, 19.3% received an early diagnosis (before 32 weeks’ gestation), while the majority, 80.7%,had a late diagnosis.
The study found that higher peak total bile acid (TBA) levels were reported in those with early ICP diagnoses. This was correlated with greater ICP severity,a history of cholestasis,a history of preterm birth,and delivery at an earlier gestational age.
Specific adverse outcomes were significantly more prevalent in the early diagnosis group:
Spontaneous Preterm Birth: 14.5% in early diagnosis vs. 6% in late diagnosis.
Iatrogenic Preterm Birth: 32% in early diagnosis vs. 14.8% in late diagnosis.
Neonatal Intensive Care Unit (NICU) Admission: 50.7% in early diagnosis vs. 37% in late diagnosis.
After adjusting for confounding factors, patients with early ICP diagnoses showed increased odds ratios (ORs) for these adverse outcomes: an OR of 1.81 for spontaneous preterm birth, 1.59 for iatrogenic preterm birth, and 1.43 for NICU admission. However, no significant associations were found with umbilical artery pH, meconium-stained amniotic fluid, or cesarean delivery for non-reassuring fetal heart tracing.
Severe ICP and its Associations
The study also identified that severe ICP occurred in 36.5% of all ICP cases, with a disproportionate number of these severe cases being diagnosed late (76.3%) compared to early (23.7%). Women with severe ICP were more likely to have a history of cholestasis, prior preterm birth, and to have received ursodeoxycholic acid treatment. They also delivered at an earlier gestational age.
Associations between severe ICP and adverse outcomes mirrored those seen in early ICP, with rates of spontaneous preterm birth at 22.2%, iatrogenic preterm birth at 38%, and NICU admission at 57.6%. These associations remained significant even after adjusting for peak TBA levels and preterm birth history.
Implications for Clinical Practice and Future Research
The findings strongly suggest that ICP diagnosed before 32 weeks’ gestation carries an increased risk of adverse neonatal outcomes.The consistency of these outcomes,even in cases of early severe ICP,leads investigators to conclude that the duration of exposure to elevated bile acids plays a crucial role.
“While this study better describes the outcomes associated with cholestasis, further studies are needed to determine the mechanism for early ICP associated spontaneous preterm birth and whether trending TBA after early diagnosis can improve outcomes,” the researchers stated.This research underscores the importance of vigilant monitoring and timely intervention for pregnant individuals diagnosed with ICP, particularly when the diagnosis occurs earlier in gestation. Further inquiry into the underlying mechanisms and potential management strategies for early ICP is warranted to improve maternal and neonatal well-being.References:
- Sarker MR, Canfield D, Ferrara L, Debolt CA. Earlier diagnosis of intrahepatic cholestasis of pregnancy and adverse pregnancy outcomes. Pregnancy. 2025. Two: 10.1002/PMF2.70073
- Brouwers L, Koster MP, Page-Christiaens GC, et al. intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol*. 2015; 212 (1): 100.E1-7. DOI: